Epizyme Articles
Milestone payments for Epizyme and Antares Pharma
3 October 2012
Epizyme earns $4 million pre-clinical milestone from GSK under novel HMT therapeutics alliance
17 October 2011
Showing 1-3 of 3 articles
- 1
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Athera and Boehringer Ingelheim enter option agreement on a novel therapy for atherosclerosis
- US Supreme Court says patent settlement can "sometimes" be illegal
- Actavis and Kissei file law suits against Sandoz and Hetero over Rapaflo patent
